When you think of Covid-19 vaccines, you probably think of Pfizer, Moderna, and Johnson & Johnson (and likely in that order!). Well, according to a recent New York Times article, there’s a new player in the vaccine game, and it’s from China’s Sinopharm. Last Friday, the World Health Organization approved the vaccine for emergency use, allowing the vaccine to be included in Covax, the W.H.O.’s global program for promoting equitable access to vaccines around the world.
W.H.O. Grants Emergency Use Authorization to Sinopharm’s Covid-19 Vaccine
The approval will likely expand vaccine availability to poorer nations amid the pandemic.
May 11, 2021
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More